Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Leon L. Lutschinger"'
Autor:
Leon L. Lutschinger, Angelos G. Rigopoulos, Peter Schlattmann, Marios Matiakis, Daniel Sedding, Paul Christian Schulze, Michel Noutsias
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and safety of colchicine in patients with pericarditis or postperic
Externí odkaz:
https://doaj.org/article/3d2794160fc6479899b4a8ab7fb68f17
Autor:
Leon L. Lutschinger, Angelos G. Rigopoulos, Peter Schlattmann, Marios Matiakis, Daniel Sedding, Paul Christian Schulze, Michel Noutsias
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-1 (2019)
After publication of the original article [1], we were notified that an author’s name is not complete.
Externí odkaz:
https://doaj.org/article/02ffe732a74d46b99c63363033c6acc3
Autor:
Marios Matiakis, Daniel Sedding, Peter Schlattmann, Michel Noutsias, Angelos G. Rigopoulos, Paul Christian Schulze, Leon L. Lutschinger
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-1 (2019)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and safety of colchicine in patients with pericarditis or postpericardiotomy syndrome (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::457b314fdcf1615ad352d0d305069ff4
https://doi.org/10.1186/s12872-019-1195-z
https://doi.org/10.1186/s12872-019-1195-z
Autor:
Paul Christian Schulze, Angelos G. Rigopoulos, Peter Schlattmann, Leon L. Lutschinger, Marios Matiakis, Daniel Sedding, Michel Noutsias
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-11 (2019)
Background Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and safety of colchicine in patients with pericarditis or postpericardiotomy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5962c395425ada158b227cde1e17102
https://doi.org/10.1186/s12872-019-1190-4
https://doi.org/10.1186/s12872-019-1190-4